Publikationen 2025
- Ahn D D, The N T, Song L H, Müller A, Velavan T P, Seliger B. Elevated soluble HLA-G levels associate with dengue severity in Vietnamese patients. J Med Virol. 2025, 97 (9):e70594. doi: 10.1002/jmv.70594
- Ammar D, Sanges C, Henderson D, Schapitz I, Hudecek M, Luu M, Schüssler-Lenz M, Buchholz C, Franz P, Reiche K, Köhl U, Ifrah N, Quesnel B, Thermeli M, Kersten M J, Locatelli F, D'Amore M L, Bonini C, Casucci M, Philippar U, Doeswijk R, Thielen F, Uyl-de Groot C, Theelen J, Schröder B, Kremer A, Quaranta M, Prosper F, Brulle J van den, Grawunder U, Donnadieu E, Galy A, Ferrand C, Worel N, Busch D, Briones J, Sellner L, Kuball J, Sureda A, Awigena-Cook J. Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe. Cytotherapy. 2026, 28 (1):101984. doi: 10.1016/j.jcyt.2025.09.007. Epub 2025 Sep 23
- Andersen J L, Banke S, Fagerberg R, Flamm C, Merkle D, Stadler P F. Pathway realizability in chemical networks. J Comput Biol. 2025, 32 (2): 164-187. doi: 10.1089/cmb.2024.0521
- Arend L, Adamowicz K, Schmidt J R, Burankova Y, Zolotareva O, Tsoy O, Pauling J K, Kalkhof S, Baumbach J, List M, Laske T. Systematic evaluation of normalization approaches in tandem mass tag and label-free protein quantification data using PRONE. Brief Bioinform. 2025, 26 (3): bbaf201. doi: 10.1093/bib/bbaf201
- Bauer M, Santos P, Wilfer A, Berg E van den, Zietsman A, Vetter M, Kaufhold S, Wickenhauser C, Dos-Santos-Silva I, Chen W C, Cubasch H, Murugan N, McCormack V, Joffe M, Seliger B, Kantelhardt E. HIV status alters immune cell infiltration and activation profile in women with breast cancer. Nat Commun. 2025, 16 (1): 4699. doi: 10.1038/s41467-025-59408-8
- Bloße A, Pirlich M, Dietz A, Möser C, Arnold K, Freitag J, Neumuth T, Smith D M, Kubitschke H, Gaenzle M. Fluorescence-guided surgery in head and neck Squamous cell carcinoma (HNSCC). Int. J. Transl. Med. 2025, 5 (3), 40. doi: 10.3390/ijtm5030040
- Blum A, Xiang W, Wien F, Thureau A, Chevreuil M, Raynal B, Geissler S, Wermann M, Schilling S, Bénas P, Hartlage-Rübsamen M, Schulze A, Sauter C, Roßner S. Monomers, dimers, and oligomers of pyroglutamate-modified α-Synuclein fragments exhibit distinct biophysical characteristics. ACS Chem Neurosci. 2025, 16 (10): 1919-1936. doi: 10.1021/acschemneuro.5c00106
- Born P, Fandrei D, Wang S Y, Perez-Fernandez C, Fischer L, Ussmann J, Bach E, Hoffmann S, Metzeler K H, Herling M, Herling C, Jentzsch M, Boldt A, Seiffert S, Baber R, Weidner H, Franke G-N, Denecke T, Sabri O, Platzbecker U, Vucinic V, Meyer H J, Kurch L, Merz M. Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma. Hemasphere. 2025, 9 (6): e70159. doi: 10.1002/hem3.70159
- Braun T, Kuschel F, Reiche K, Merz M, Herling M. Emerging T-cell lymphomas after CAR T-cell therapy. Leukemia. 2025, 9 (6): 1337-1341. doi: 10.1038/s41375-025-02574-x
- Braun T, Rade M, Merz M, Klepzig H, Große F, Fandrei D, Pham N-N, Kreuz M, Kuhn C K, Kuschel F, Löffler D, Meinel J, Heger E, Schweinsberg V, Pflug N, Platzbecker U, Hallek M, Holtick U, Köhl U, Scheid C, Reiche K, Herling M, Richardson T. Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody. Nat Med. 2025, 31 (4): 1145-1153. doi: 10.1038/s41591-025-03499-9
- Burankova Y, Abele M, Bakhtiari M, Toerne C von, Barth T K, Schweizer L, Giesbertz P, Schmidt J R, Kalkhof S, Müller-Deile J, Veelen P A van, Mohammed Y, Hammer E, Arend L, Adamowicz K, Laske T, Hartebrodt A, Frisch T, Meng C, Matschinske J, Späth J, Röttger R, Schwämmle V, Hauck S M, Lichtenthaler S F, Imhof A, Mann M, Ludwig C, Kuster B, Baumbach J, Zolotareva O. Privacy-preserving multicenter differential protein abundance analysis with FedProt. Nat Comput Sci. 2025, 5 (8): 675-688. doi: 10.1038/s43588-025-00832-7
- Cavina L, Alocén Portillo A, Balmer M P A, Dammer J C, Schillemans D, Hamdani S H, Ackerschott B, Dieteren C E J, Martina B E E, Buuren B N M van, Rockstroh A, Ulbert S, Hermkens P H H, Llinàs Brunet M, Gironés D, Feiters M, Rutjes F P J T. Development of lipopeptides as orthoflavivirin inhibitors with low micromolar broad-spectrum antiorthoflaviviral activity. J Med Chem. 2025, 68 (21): 22386-22400. doi: 10.1021/acs.jmedchem.5c01364
- Ciok M, Diener J, Otte F, Feimer J, Nichterlein M, Kalkhof S, Noll M. Biocide-containing facades alter culture-based bacterial and fungal community composition and resistance patterns to octylisothiazolinone. Microorganisms. 2025, 13 (10): 2284. doi: 10.3390/microorganisms13102284
- Coşkuner Leineweber Ö, Pothineni B K, Schumann N, Hofmann U, Möser C, Smith D M, Grundmeier G, Zhang Y, Keller A. Vancomycin-modified DNA origami nanostructures for targeting bacterial pathogens. Small Structures 2025, 6 (12): e202500246. doi: 10.1002/sstr.202500246
- Couto P S, Stibbs D J, Springuel P, Schultz U, Effenberger M, Goldrick S, Navarro-Velázquez S, Juan M, Herbst L, Nießing B, Mestermann K, Sanges C, Hudecek M, Rafiq Q A. Impact of serum/xeno-free medium and cytokine supplementation on CAR-T cell therapy manufacturing in stirred tank bioreactors. Biotechnol J. 2025, 20 (9): e70114. doi: 10.1002/biot.70114
- De Angelis B, D'Amore M L, Lecot P, Neininger K, Lorrain M, Gambotti L, Dreuillet C, Courcault E, Chatterjee S, Delgado J, Galy A, Franz P, Rodriguez-Madoz J R, Cabrerizo Y, Richter A, Girvalaki C, Noviello M, Tassi E, Sanges C, Luu M, Hudecek M, Kremer A, Locatelli F, Negre H, Quintarelli C. European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring. Front Immunol. 2025, 16: 1567582. doi: 10.3389/fimmu.2025.1567582
- Di Giacomo A M, Subudhi S, Vos W, Andreatta M, Carmona S, McTavish W, Seliger B, Ibrahim R, Lahn M, Smith M, Eggermont A, Fox B A, Maio M. Perspectives on the role of “-Omics” in predicting response to immunotherapy. Eur J Cancer. 2025, 220: 115393. doi: 10.1016/j.ejca.2025.115393
- Eick S, Taudte N, Ramsbeck D, Magdon A, Sculean A, Potempa J, Buchholz M. Effect of a bacterial glutaminyl cyclase inhibitor on multi-species-biofilms. Front. Oral Health, 01 December 2025, Sec. Oral Infections and Microbes, Volume 6 - 2025. doi: 10.3389/froh.2025.1716625
- Fanti Z, Braumann U-D, Rauscher F G, Ebert T, Bribiesca E, Martinez-Perez M E. Slope chain code-based scale-independent tortuosity measurement on retinal vessels. Exp Eye Res. 2025, 254: 110286. doi: 10.1016/j.exer.2025.110286
- Ferle M, Grieb N, Kreuz M, Ader J, Goldschmidt H, Mai E K, Bertsch U, Platzbecker U, Neumuth T, Reiche K, Oeser A, Merz M. Predicting progression events in multiple myeloma from routine blood work. NPJ Digit Med. 2025, 8 (1): 231. doi: 10.1038/s41746-025-01636-9
- Fertey J, Makert G R, Becker P, Finkensieper J, Ulbert S. Low-energy electron irradiation inactivates viruses in serum and maintains growth-promoting properties in cell culture. Appl Biosaf. 2025, 30 (3): 264-271. doi: 10.1089/apb.2024.0031
- Filippi Xavier L, Gacesa R, Oliveira Da Rocha G H, Broering M F, Scharf P, Silva Lima F da, Faber K N, Harmsen H, Hoffmann C, Poliselli Farsky S H. Annexin A1 levels affect microbiota in health and DSS-induced colitis/inflammatory bowel disease development. Front. Immunol 2025, 16: 1679071. doi: 10.3389/fimmu.2025.1679071
- Friedrich VD, Neier K, Müller K, Fogal B, Loncova Z, Rade M, Shoaib M, Köhl U, Hoyt K, Pande P, Blanchard L, Raymond E, Scholz M, Reiche K, Kirsten H. Deep learning-aided inter-species-comparison reveals shared and distinct molecular patterns in cynomolgus monkey and humans following non-specific T cell activation. Front Immunol. 2025, 16: 1603716. doi: 10.3389/fimmu.2025.1603716
- Gogesch P, Iannazzo S O, Rupp N, Rom J, Kreuz M, Reiche K, Anzaghe M, Waibler Z, on behalf the imSAVAR Consortium. Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeability. PLoS One. 2025, 20 (8): e0329700. doi: 10.1371/journal.pone.0329700
- Haupt J, Keminer O, Neser C, Windshügel B, Wiltzsch V, Schmidt J, Pliushcheuskaya P, Künze G, Scholz U, Müller C, Oliveira da Rocha G H, Biermann M, Zdzieblo D, Metzger M, Schiefke I, Neurath M, Siegmund B, Claussen C, Köhl U, Geisslinger G, Buchholz M, Kalkhof S, Lehmann J. Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing. Biochem Pharmacol. 2025, 240: 117066. doi: 10.1016/j.bcp.2025.117066
- Horbas H, Bauer M, Eckert A, Bethmann D, Wilfer A, Seliger B, Wickenhauser C. Comparison of manual versus QuPath software-based immunohistochemical scoring using oral squamous cell carcinoma as a model. J Histochem Cytochem. 2025, 73 (5-6): 181-196. doi: 10.1369/00221554251335698
- Jaeckel E, Friedman S L, Hudecek M, Protzer U. Chimeric antigen receptor (CAR) T-cell therapy: engineering immune cells to treat liver diseases. Review J Hepatol. 2025, 83 (5): 1156-1171. doi: 10.1016/j.jhep.2025.06.007
- Keitel V, Kreissl MC, Goetze T, Dröge C, Kuhn CK, Pham NN, Löffler D, Borie D, Schreiber J, Boettcher M, Hippe K, Pech M, Mikusko M, Köhl U, Walther D, Reiche K, Mougiakakos D. CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement. J Hepatol. 2025 Dec 8:S0168-8278(25)02711-4. doi: 10.1016/j.jhep.2025.11.027
- Kiefer N, Klein J, Beyer F, Burghardt B, Rohr M, Klein M, Burghardt M, Noll M, Kalkhof S. Experimental and computational identification of essential parameters governing biocide distribution in soil. Environ Toxicol Chem. 2025, 44 (10): 3037-3050. doi: 10.1093/etojnl/vgaf156
- Kiefer N, Klein J, Rohr M, Noll M, Burkhart M, Klein M, Kalkhof S. Simulation of the biocide distribution in soil using PELMO coupled with COMLEAM. Environ Sci Pollut Res Int. 2025, 32 (5): 2425-2440. doi: 10.1007/s11356-024-35760-y
- Kirchhoff H, Schoenherr C, Fleischer L, Schweighart E K, Esser R, Talbot S R, Schambach A, Köhl U, Heidenreich O, Eder M, Scherr M. Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia. Hemasphere. 2025, 9 (10): e70238. doi: 10.1002/hem3.70238
- Kitte R, Serfling R, Blache U, Seitz C, Schrader S, Köhl U, Fricke S, Bär C, Tretbar S U. Optimal chimeric antigen receptor (CAR)-mRNA for transient CAR T cell generation. Int J Mol Sci. 2025, 26 (3): 965. doi: 10.3390/ijms26030965
- Körtge A, Kamper C, Klinkmann G, Wasserkort R, Mitzner S. In vitro assessment of drug adsorption profiles during hemoadsorption therapy. Blood Purif. 2025, 54 (4-5): 218-225. doi: 10.1159/000545120
- Krames W E A, Dayi D I, Kaiser L, Riester O, Himmelhaus M, Csuk R, Deigner H-P. WGM sensors for future diagnostics: small molecules to whole organisms. Biosens. Bioelectron. (UK). 2025, 26: 100671. doi: 10.1016/j.biosx.2025.100671
- Kurz K S, Steinlein S, Kreuz M, Ziepert M, Staiger A M, Barth T F E, Möller P, Bernd H-W, Feller A C, Richter J, Klapper W, Stein H, Hartmann S, Hansmann M-L, Trümper L, Loeffler M, Schmitz N, Rosenwald A, Ott G, Horn H, DSHNHL/GLA. Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: results from clinical trials of the DSHNHL/GLA. Hemasphere. 2025, 9 (3): e70093. doi: 10.1002/hem3.70093
- Lehmann S, Lange U G, Oberbach A, Retschlag U, Morgenroth R, Busse H, Prettin C, Petroff D, Seidemann L, Blüher M, Dietrich A. The effect of 6 months of structured strength or endurance exercise program on weight loss after gastric bypass surgery in a randomized controlled trial. Langenbecks Arch Surg. 2025, ;410 (1): 194. doi: 10.1007/s00423-025-03731-7
- Marton C, Clémenceau B, Dachy G, Demerle C, Derenne S, Ferrand C, Giverne C, Latouche J-B, Lemée L, Martinet J, Bonig H, Bensoussan D, Chabannon C, Köhl U, Deschamps M, Vos J de, Diana J, Dougé A, Forcade E, Galaine J, Thiant S, Galy A, Larghero J, Reppel L, Viel S, Boyer O, Yakoub-Agha I. Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium. Bone Marrow Transplant. 2025, 60 (9): 1209-1217. doi: 10.1038/s41409-025-02637-8
- Mazein A, Lopata O, Reiche K, Sewald K, Alb M, Sakellariou C, Gogesch P, Morgan H, Neuhaus V, Pham N-N, Sommer C, Perkins E, Fogal B, Shoaib M, Schneider R, Satagopam V, Ostaszewski M. An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies. Front Immunol. 2025, 16: 1601670. doi: 10.3389/fimmu.2025.1601670
- Nelz S-C, Lück E, Schölzel A, Sauer M, Heskamp J, Doss S. Ex vivo plasma application on human brain microvascular endothelial-like cells for blood-brain barrier modeling. Int J Mol Sci. 2025, 26 (7): 3334. doi: 10.3390/ijms26073334
- Nguven T T, Ho P, Staudt S, Gregoire C, Ziegler-Martin K, Jassin M, Block A, Hudecek M, Melenhorst J, Caers J, Luu M. Fine tuning towards the next generation of engineered T cells. Nat Biomed Eng. 2025, 9 (10): 1610-1631. doi: 10.1038/s41551-025-01492-8
- Nichterlein M, Kiefer N, Hohner J, Stapf D, Schatz M, Noll M, Kalkhof S. Encapsulated biocides in facade materials impact leaching and UV stability, resulting in lower aquatic toxicity of the eluates. Environ Sci Pollut Res Int. 2025, 32 (27): 16324-16339. doi: 10.1007/s11356-025-36647-2
- Peña‑Rodríguez A, Ramírez‑Sánchez I, Leptihn S, Quiroz‑Guzmán E. A novel vibriophage vB_Vp_PvVp04 against pathogenic Vibrio parahaemolyticus and its formulation for inclusion in shrimp feed. Aquaculture Int. 2025, 33: 117. doi: 10.1007/s10499-024-01797-6
- Pennings E R, Spanjaart A M, Thielen F W, Oerlemans S, Fleischer A, Sanges C, Gomes Da Silva M, Cabrerizo Y, Lecot P, Roux-Opstaele L, Dreuillet C, Gonzalez-Marcano E, Millán O, Jaeger U, Delgado J, Luu M, Huber B, Lorrain M, Galhardas Pina M, Kremer A, Bolanos N, Clavreul S, Nier S, Liu R D K, Lissenberg-Witte B I, Anguille S, Robin M, Morris E C, Sureda A, Préau M, Pannard M, Bock G H de, Wagers S S, Trebeden-Negre H, Maucort-Boulch D, Hudecek M, Uyl-de Groot C A, Kersten M. Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe. Blood Adv. 2025, 9 (24): 6380-6393. doi: 10.1182/bloodadvances.2025017081
- Petri K, D'Ippolito E, Künkele A, Köhl U, Busch D H, Einsele H, Hudecek M. Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities. Nat Rev Clin Oncol. 2025, 22 (12): 902-923. doi: 10.1038/s41571-025-01072-4
- Petroni G, Galassi C, Gouin K H, Chen H-H, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea C E, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty A M, Rippon B, Finotello F, Trajanoski Z, Zhou X K, Scandura J M, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz M E, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho R K, Shiao S L, McArthur H L, Formenti S C, Knott S R V, Galluzzi L. IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages. Nat Cancer. 2025, 6 (10): 1656-1675. doi: 10.1038/s43018-025-01007-z
- Popp G, Jöckel L, Kläs M, Wiener T, Hilger N, Stumpf N, Groß J, Dünkel A, Blache U, Fricke S, Franz P. A user-centric approach to reliable automated flow cytometry data analysis for biomedical applications. Cytometry A. 2025, 107 (2): 111-125. doi: 10.1002/cyto.a.24913
- Rade M, Fandrei D, Kreuz M, Seiffert S, Grahnert A, Friedrich M, Wiemers T, Born P, Fischer L, Weidner H, Hofbauer LC, Baber R, Wang SY, Bach E, Hoffmann S, Scolnick J, Friedrich M, Keramati F, Brazda P, Sebestyen Z, Kuball J, Alb M, Scheller L, Hudecek M, Einsele H, Metzeler KH, Herling M, Herling CD, Jentzsch M, Franke GN, Boldt A, Köhl U, Platzbecker U, Vucinic V, Reiche K, Merz M. A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma. Cancer Cell. 2025, S1535-6108 (25) 00490-8. doi: 10.1016/j.ccell.2025.10.014
- Reis T, Ramírez-Guerrero G, Pecoits-Filho R, Lorenzin A, Cal M de, Corradi V, Klinkmann G, Ronco F, Neves F A R, Bellomo R, Ronco C. Iodinated contrast adsorption in cartridges with styrene-divinylbenzene sorbent. Artif Organs. 2025, 49 (5): 813-819. doi: 10.1111/aor.14949
- Reiß F, Kiefer N, Tanunchai B, Reiss P, Kalkhof S, Noll M. Continuous intake of facade eluates affects active and total soil Microbiome. Biol. Fertil. Soils. 2025, 62: 75-95. doi: 10.1007/s00374-025-01955-9
- Renner A, Finkbeiner M S C, Haas F V, Stahringer A, Lindow M, Delaroque N, Szardenings M, Fricke S, Köhl U, Engeland C E, Schmiedel D. Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy. Mol Ther Oncol. 2025, 33 (4): 201043. doi: 10.1016/j.omton.2025.201043
- Riester Z, Surowka M, Seifert N, Darowski D, Ghosh A, Spieler P, Weber J, Gianotti R, Freitag F, Alb M, Nerreter T, Gerhard-Hartmann E, Rosenwald A, Sauer M, Moessner E, Einsele H, Ferrara-Koller C, Klein C, Hudecek M, Danhof S. Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma. Mol Ther. 2025, S1525-0016(25)00867-6. doi: 10.1016/j.ymthe.2025.10.046
- Ritter J, Falckenhayn C, Qi M, Gather L, Gutjahr D, Schmidt J, Simm S, Kalkhof S, Hildebrand J, Bosch T, Winnefeld M, Grönniger E, Siracusa A. Systemic factors in young human serum influence in vitro responses of human skin and bone marrow-derived blood cells in a microphysiological co-culture system. Aging (Albany NY). 2025, 17 (7): 1784-1809. doi: 10.18632/aging.206288
- Roßbach L, Eichenberg T, Pietzsch N, Franz P, Fricke S, Sieg R, Dünkel A, Adlkofer KS. "Live" cell shipment-a forward-looking transport option for cryo-sensitive cell-based therapies. Front Bioeng Biotechnol. 2025, 13: 1706927. doi: 10.3389/fbioe.2025.1706927
- Salti H, Nelz S-C, Lichtwark S, Pohl C, Kramer L, Lorenz M, Lemcke H, Doss S, Mitzner S, Wasserkort R. Recellularization of Scaffolds derived from precision-cut kidney slices. Biomed Mater. 2025, 20 (6). doi: 10.1088/1748-605X/ae05a4
- Sandetskaya N, Kölsch A, Mattern K, Vater V, Kuhlmeier D, Priller F. CampyTube: Seamless Integration of a Molecular Test and Lateral Flow Detection of Campylobacter in a Single Vial. Biosensors (Basel). 2025, 15 (8), 497. doi: 10.3390/bios15080497
- Sattler T, Benka B, Zimpernik I, Pürrer S, Waldner K, Duscher G G, Kuffer-Rosewick A, Fertey J, Ulbert S, Schmoll F. Retrospective cross-sectional study of occupational infection risk with zoonotic pathogens in austrian veterinary practitioners in the year 2022. Vet Med Sci. 2025, 11 (5): e70485. doi: 10.1002/vms3.70485
- Scheller L, Zhou X, Loeffler-Wirth H, Kreuz M, Kadel SK, Schimanski S, Schulze H, Ruckdeschel A, Eisele F, Konetzki V, Jornet Culubret M, Merz M, Mersi J, Waldschmidt J, Danhof S, Köhl U, Kortüm KM, Rasche L, Einsele H, Düll J, Topp MS, Hudecek M, Reiche K, Alb M. Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy. Hemasphere. 2025, 9 (12): e70267. doi: 10.1002/hem3.70267
- Schindler-Wnek K, Stahringer A, Heimer N, Köhl U, Fricke S, Schmiedel D. Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies. Oncoimmunology. 2025, 14 (1): 2546443. doi: 10.1080/2162402X.2025.2546443
- Schmidt J, Sopel N, Rist C, Ohs A, Dawid L, Simm S, Catanese L, Rupprecht H, Jobst-Schwan T, Lehmann J, Daniel C, Kalkhof S, Schiffer M, Müller-Deile J. Dysregulated protease homeostasis defines primary focal segmental glomerulosclerosis. Kidney360. 2025. ahead of print. doi: 10.34067/KID.0000001021
- Schwarzer A, Ziegler U, Fertey J, Kreuz M, Vahlenkamp T W, Groschup M H, Ulbert S. Serological differentiation of West Nile, Usutu, and tick-borne encephalitis virus antibodies in birds and horses using mutant E protein ELISAs. Sci Rep. 2025, 15 (1): 28752. doi: 10.1038/s41598-025-14448-4
- Seiffert S, Blaudszun, A-R, Shibru B, Körfer J, Köhl U, Fricke S, Sack U, Boldt A. Differential expression of immune checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on circulating natural killer cells - insights from healthy donors compared to gastric cancer patients. Oncol Res Treat. 2025, 48 (10): 585-600. doi: 10.1159/000545429
- Seiffert S, Kirchberg J, Bach E, Menger V, Brückner M, Sack U, Köhl U, Platzbecker U, Boldt A, Herling M, Vučinić V. Extracorporeal photopheresis - new insights into an old procedure. Transfus Med. 2025 Jun 10. doi: doi: 10.1111/tme.13156
- Seliger B, Massa C. CyTOF as a suitable tool for stratification and monitoring of cancer patients. J Transl Med. 2025, 23 (1): 724. doi: 10.1186/s12967-025-06764-0
- Selpiev Z, Leptihn S, Müsken M, Loh B. Deciphering shared receptor usage in genomically unrelated bacteriophages infecting hypervirulent Klebsiella pneumoniae K1 ST23. FEMS Microbes. 2025, 6: xtaf014. doi: 10.1093/femsmc/xtaf014
- Song Y, Lee S, Heo S-W, Spohn J, Schmiedel D, Heo T, Kim S, Park J, Seo H R. HO-1197 as a multifaceted therapeutic: targeting the cell cycle, angiogenesis, metastasis, and tumor immunity in hepatocellular carcinoma. Int J Mol Sci. 2025, 26 (21): 10329. doi: 10.3390/ijms262110329
- Stubenvoll A, Schmidt M, Moeller J, Lingner Chango M A, Schultz C, Antoniadou O, Loeffler-Wirth H, Bernhart S, Große F, Thier B, Paschen A, Anderegg U, Simon J C, Ziemer M, Schoeder C T, Binder H, Kunz M. Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity. Cancer Commun (Lond). 2025, 45 (4): 465-470. doi: 10.1002/cac2.12651
- Subbarayan K, Bieber H, Massa C, Rodríguez F A E, Hossain S M AA, Neuder L, Wahbi W, Salo T, Tretbar S, Al-Samadi A, Seliger B. Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers. J Transl Med. 2025, 23 (1): 294. doi: 10.1186/s12967-025-06177-z
- Tony L T, Stabile A, Schauer M P, Hudecek M, Weber J. CAR-T cell therapy for solid tumors. Transfus Med Hemother. 2025, 52 (1): 96–108. doi: 10.1159/000542438
- Udinotti M, Sieboldts U, Bauer M, Vaxevanis C, Asiminas A, Lorenz K, Dierks C, Wickenhauser C, Seliger B. Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer. J Transl Med. 2025, 23 (1): 1284. doi: 10.1186/s12967-025-07307-3
- Uhlmann L, Pierer M, Krasselt M, Franke G, Zeidler R, Sabri O, Denecke T, Sack U, Köhl U, Boldt A, Borie D, Wagner U, Platzbecker U, Vucinic V. Effective use of anti-CD19 chimeric antigen receptor T cells in a case of treatment-resistant granulomatosis with polyangiitis. Ann Rheum Dis. 2025, 84 (7): 1280-1283. doi: 10.1016/j.ard.2025.04.029
- Weber J, Rade M, Michael J, Tony L T, Freitag F, Spieler P, Müller C, Kalogirou C, Mainz L, Lehmann J, Klopfleisch R, Rosenfeldt M T, Danhof S, Kortüm K M, Köhl U, Einsele H, Rader C, Reiche K, Nerreter T, Hudecek M. ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice. Cell Rep Med. 2025, 6 (10): 102400. doi: 10.1016/j.xcrm.2025.102400
- Wegner V D, Feile A, Alb M, Hudecek M, Hewitt P, Mosig A S. Short-chain fatty acids modulate anti-ROR1 CAR T-cell function and exhaustion in an intestinal adenocarcinoma-on-chip model. Adv Healthc Mater. 2025 May;14(13):e2405003. Epub 2025 Apr 18. doi: 10.1002/adhm.202405003
- Weirauch U, Kreuz M, Birkenbihl C, Alb M, Quaranta M, Calzone L, Orozco-Ruiz S, Binder S, Fischer L, Clavreul S, Maguri M, Ferle M, Rade M, Azarias G, Hydren J R, Jamarik J, Schwarz D, Sebestyen Z, Kuball J, Popp G, Antoine C, Knockaert M, Schoeder C T, Fandrei D, Sanges C, Radvilas V, Gagelmann N, Rückert M, Penack O, Fricke S, Schmidt A, Ward C, Steinbeisser C, Van Gyseghem J-M, Niarakis A, Garderet L, Hudecek M, Neumuth T, Platzbecker U, Köhl U, Demlova R, Kremer A, Franke S, Fröhlich H, Merz M, Reiche K, CERTAINTY Consortium. Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies. NPJ Digit Med. 2025, 8 (1): 493. doi: 10.1038/s41746-025-01809-6
- Wiemers T, Ferle M, Ader J, Sotikova V, Fandrei D, Grieb N, Fischer L, Born P, Weidner H, Wang S Y, Jentzsch M, Franke G-N, Herling C, Metzeler K, Herling M, Heyn S, Denecke T, Reiche K, Platzbecker U, Vucinic V, Neumuth T, Meyer H-J, Merz M. Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma. Transplant Cell Ther. 2025, 31 (10): 789-803. doi: 10.1016/j.jtct.2025.07.003
- Wiltzsch V, Schmidt J R, Adamowicz K, Lauterbach T, Lehmann J, Baumbach J, Laske T, Kalkhof S. Systematic comparison of bone proteome extraction methods to allow for integrated proteomics-metabolomics correlation. J Proteome Res. 2025, 24 (9): 4362-4376. doi: 10.1021/acs.jproteome.4c01060
- Yanik S D, Jameel K J, Rohde S, Bürger P, Bülthoff E, Grunwald T, Kronsbein J, Koch A, Edwards M R, Tenbusch M, Knobloch J. Cytokine production of mononuclear leukocytes in response to respiratory syncytial virus is increased in COPD but suppressed in non-COPD tobacco smokers. Mol Med. 2025 Jun 12;31(1):237. doi: 10.1186/s10020-025-01277-4
- Ye J L, Grieger K, Lu D, Brandenberger C, Juchem M, Jordan M, Oehlsen L, Zardo P, Werlein C, Hesse C, Sewald K, Tretbar S, Thum T, Chatterjee S, Bär C. Telomerase modRNA offers a novel RNA-based approachto treat human pulmonary fibrosis. Aging Cell. 2025, 24 (11): e70240. doi: 10.1111/acel.70240